Cargando…
P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY.
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430745/ http://dx.doi.org/10.1097/01.HS9.0000972092.74829.03 |
| _version_ | 1785091040031539200 |
|---|---|
| author | Gabeeva, Nelli Smolyaninova, Anna Belyaeva, Anastasia Tatarnicova, Svetlana Kovrigina, Alla Badmazhapova, Darima Koroleva, Daria Gemdzhian, Eduard Obukhova, Tatiana Sudarikov, Andrey Zvonkov, Evgeniy |
| author_facet | Gabeeva, Nelli Smolyaninova, Anna Belyaeva, Anastasia Tatarnicova, Svetlana Kovrigina, Alla Badmazhapova, Darima Koroleva, Daria Gemdzhian, Eduard Obukhova, Tatiana Sudarikov, Andrey Zvonkov, Evgeniy |
| author_sort | Gabeeva, Nelli |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430745 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104307452023-08-17 P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY. Gabeeva, Nelli Smolyaninova, Anna Belyaeva, Anastasia Tatarnicova, Svetlana Kovrigina, Alla Badmazhapova, Darima Koroleva, Daria Gemdzhian, Eduard Obukhova, Tatiana Sudarikov, Andrey Zvonkov, Evgeniy Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430745/ http://dx.doi.org/10.1097/01.HS9.0000972092.74829.03 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Gabeeva, Nelli Smolyaninova, Anna Belyaeva, Anastasia Tatarnicova, Svetlana Kovrigina, Alla Badmazhapova, Darima Koroleva, Daria Gemdzhian, Eduard Obukhova, Tatiana Sudarikov, Andrey Zvonkov, Evgeniy P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY. |
| title | P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY. |
| title_full | P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY. |
| title_fullStr | P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY. |
| title_full_unstemmed | P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY. |
| title_short | P1301: HIGH-DOSE THERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION AS THE FIRST-LINE THERAPY OF FOLLICULAR LYMPHOMA: RESULTS FROM A PROSPECTIVE SINGLE-CENTER STUDY. |
| title_sort | p1301: high-dose therapy with autologous stem cell transplantation as the first-line therapy of follicular lymphoma: results from a prospective single-center study. |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430745/ http://dx.doi.org/10.1097/01.HS9.0000972092.74829.03 |
| work_keys_str_mv | AT gabeevanelli p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT smolyaninovaanna p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT belyaevaanastasia p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT tatarnicovasvetlana p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT kovriginaalla p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT badmazhapovadarima p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT korolevadaria p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT gemdzhianeduard p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT obukhovatatiana p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT sudarikovandrey p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy AT zvonkovevgeniy p1301highdosetherapywithautologousstemcelltransplantationasthefirstlinetherapyoffollicularlymphomaresultsfromaprospectivesinglecenterstudy |